» Articles » PMID: 8168059

A Technique for Using Neural Network Analysis to Perform Survival Analysis of Censored Data

Overview
Journal Cancer Lett
Specialty Oncology
Date 1994 Mar 15
PMID 8168059
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to demonstrate how a form of neural network analysis could be used to perform survival analysis on censored data, and to compare neural network analysis with the most commonly used technique for this type of analysis, Cox regression. In this study computer simulated data sets were used. The underlying rules connecting prognostic information to the hazard of death were defined to allow the construction of data sets with specific realistic properties that could be used to demonstrate situations in which neural network analysis had particular strengths in comparison with Cox regression modeling. Using these simulated data sets neural network analysis could produce successful predictive models, find interactions between variables, and recognize the importance of variables that contributed to the hazard rate as a complex function of the variables value and in situations where the proportionality of hazards assumption was violated. It was also demonstrated that neural network analysis was not a 'black box', but could lead to useful insights into the roles played by different prognostic variables in determining patient outcome.

Citing Articles

Advancing healthcare: the role and impact of AI and foundation models.

Mahesh N, Devishamani C, Raghu K, Mahalingam M, Bysani P, Chakravarthy A Am J Transl Res. 2024; 16(6):2166-2179.

PMID: 39006256 PMC: 11236664. DOI: 10.62347/WQWV9220.


Artificial intelligence, machine learning, and deep learning for clinical outcome prediction.

Pettit R, Fullem R, Cheng C, Amos C Emerg Top Life Sci. 2021; .

PMID: 34927670 PMC: 8786279. DOI: 10.1042/ETLS20210246.


A novel diagnostic and prognostic approach for unresponsive patients with anthroponotic cutaneous leishmaniasis using artificial neural networks.

Bamorovat M, Sharifi I, Rashedi E, Shafiian A, Sharifi F, Khosravi A PLoS One. 2021; 16(5):e0250904.

PMID: 33951081 PMC: 8099060. DOI: 10.1371/journal.pone.0250904.


Application of artificial neural network-based survival analysis on two breast cancer datasets.

Chi C, Street W, Wolberg W AMIA Annu Symp Proc. 2008; :130-4.

PMID: 18693812 PMC: 2813661.


Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.

Cucchetti A, Vivarelli M, Heaton N, Phillips S, Piscaglia F, Bolondi L Gut. 2006; 56(2):253-8.

PMID: 16809421 PMC: 1856758. DOI: 10.1136/gut.2005.084434.